Disclosures for "Effect of Patisiran on Polyneuropathy and Cardiomyopathy in Patients with hATTR Amyloidosis with V122I/T60A Variants: A Phase 4 Observational Study")
-
Raymond L. Comenzo has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Raymond L. Comenzo has received intellectual property interests from a discovery or technology relating to health care. Raymond L. Comenzo has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Shu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Shu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Shu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Shu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Shu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Shu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Shu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for The CM Group. Dr. Shu has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for T&Associates. The institution of Dr. Shu has received research support from Biogen. The institution of Dr. Shu has received research support from Alnylam.
-
Dr. Malhotra has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer Inc.. Dr. Malhotra has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Pfizer Inc. . Dr. Malhotra has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alnylam Therapeutics.
-
Dr. Hussain has nothing to disclose.
-
Dr. Zolty has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Zolty has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Zolty has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam.
-
Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acceleron. Dr. Desai has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
-
Dr. Fernandez MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zoll. The institution of Dr. Fernandez MD has received research support from Pfizer.
-
Dr. Yureneva has received personal compensation for serving as an employee of Alnylam. Dr. Yureneva has stock in Alnylam.
-
Ms. Chou has received personal compensation for serving as an employee of Alnylam Pharmaceuticals, Inc..
-
Dr. Capocelli has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Capocelli has stock in Alnylam Pharmaceuticals.